Riskpilot← Back to searchSign inGet full accessSurgTech STHLM AB
ABActiveOrg 5593866394Fiskarudden ElfvikHospital activities · NACE 8610Est. 20221 employees
Revenue 2024
SEK 157K
-63% vs 2023
EBITDA margin
22.3%
-87% vs 2023
Equity ratio
74.4%
Financial strength
Net profit 2024
SEK 29K
-87% vs 2023
| Revenue | SEK 157K | -63% |
| EBITDA | SEK 35K | -87% |
| Net profit | SEK 29K | -87% |
| Total assets | SEK 164K | -58% |
| Equity | SEK 122K | -50% |
| Employees | 1 | — |
Legal name
SurgTech STHLM AB
Org number
5593866394
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
28 juni 2022
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget ska bedriva konsultverksamhet och utbildning inom kirurgisk vård samt därmed förenlig verksamhet. Utveckla och sälja medicinteknisk utrustning samt därmed förenlig verksamhet. Äga och förvalta värdepapper och fastigheter.
Address
Fiskarudden Elfvik
Email
marcus.reuterwall@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 198 | 198 | 429 | 157 |
| Staff expenses | — | −15 | — | — |
| EBITDA | 128 | 128 | 269 | 35 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | 128 | 128 | 269 | 35 |
| Net financials | — | 0 | 4 | 1 |
| Profit before tax | 128 | 128 | 273 | 37 |
| Tax | −27 | 27 | −56 | −8 |
| Net profit | 101 | 101 | 217 | 29 |
| Item | 2022 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 233 | 233 | 390 | 164 |
| Equity | 126 | 5 543 | 242 | 122 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 107 | 107 | 148 | 42 |
| Total debt | 107 | 107 | 148 | 42 |
EBITDA margin
22.3%
This company
15.8%
Market median
+41% vs market
20222024
Equity ratio
74.4%
This company
38.2%
Market median
+95% vs market
20222024
Return on equity
23.8%
This company
18.4%
Market median
+29% vs market
20222024
Net profit margin
18.5%
This company
8.1%
Market median
+128% vs market
20222024
Asset turnover
0.96×
This company
1.12×
Market median
+14% vs market
20222024
Debt / equity
0.34×
This company
0.62×
Market median
+45% vs market
20222024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-06-28 – 2022-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-06-01 – 2022-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SurgTech STHLM AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Katarina Reuterwall | Deputy Board Member | 0 companies |
| John-Marcus C C Reuterwall Hansson | Board of Directors | 0 companies |